相关实验视频
Updated: Jul 7, 2025

08:25
Identification of Circular RNAs using RNA Sequencing
Published on: November 14, 2019
12.3K
循环RNA:一个有希望的疫苗新星
Jindong Xie1, Fengxi Ye2, Xinpei Deng1
1State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong Province, China.
Journal of translational internal medicine
|December 22, 2023
概括
循环RNAs (circRNAs) 提供了持久的,可翻译的疫苗潜力. 本综述涵盖了circRNA生物学,合成,输送和目前用于免疫治疗的疫苗开发.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 循环RNAs (circRNAs) 是稳定的,共封闭的RNA分子,耐降解.
- 某些circRNA具有可翻译的特性,使其可用作新型疫苗平台.
- 疫苗对于免疫疗法至关重要,通过激活免疫系统来准传染病和癌症.
研究的目的:
- 审查当前对可翻译circRNAs的理解.
- 探索分子生物学,合成和circRNA疫苗的输送.
- 总结最近在circRNA疫苗开发方面的进展,挑战和未来方向.
主要方法:
- 关于circRNA生物学和疫苗应用的文献综述.
- 分析 circRNA 翻译和免疫性背后的分子机制.
- 合成和 *in vitro*/*in vivo* 测试 circRNA 候选疫苗.
主要成果:
- 已确立的circRNAs作为持久且可能可翻译的疫苗候选人.
- 证明了circRNA疫苗的成功合成和初步测试.
- 确定了未来该领域的研究和开发的关键领域.
结论:
- 循环RNA疫苗代表了疫苗技术的一个有前途的新前沿.
- 对circRNA生物学和传递的进一步研究对于临床翻译至关重要.
- 循环RNA疫苗具有各种治疗应用的潜力,包括癌症免疫疗法.
相关概念视频
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Cancer Vaccines
370
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
370
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K

